Treace Medical Concepts

Treace Medical Concepts Current Liabilities

The Current Liabilities of Treace Medical Concepts (TMCI) as of Nov 10, 2026 is 30.63 M USD. In the previous year, Current Liabilities was 59.23 M USD — a change of -48.28% (lower).

Current Liabilities

30.63 MUSD

YoY

-48.28%

Last updated:

Current Liabilities of Treace Medical Concepts is 2025 30.63 M USD. Current Liabilities of Treace Medical Concepts was 2024 59.23 M USD. It decreases by -48.28% lower compared to the previous year.

The Treace Medical Concepts Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2019
13.73 M USD
Jan 1, 2020
19.10 M USD
Jan 1, 2021
32.41 M USD
Jan 1, 2022
51.85 M USD
Jan 1, 2023
75.20 M USD
Jan 1, 2024
59.23 M USD
Jan 1, 2025
30.63 M USD
The Treace Medical Concepts Current Liabilities history
YEARCurrent LiabilitiesYoY
30.63 MUSD-48.28%
59.23 MUSD-21.24%
75.20 MUSD+45.05%
51.85 MUSD+59.97%
32.41 MUSD+69.70%
19.10 MUSD+39.08%
13.73 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Treace Medical Concepts Stock analysis

What does Treace Medical Concepts do? Treace Medical Concepts Inc is a US-based medical technology company that specializes in the development, manufacturing, and marketing of innovative orthopedic solutions. The company was founded in 2013 by John Treace and is headquartered in Palm Beach Gardens, Florida. The history of Treace Medical Concepts began with a simple idea. Founder John Treace was an orthopedic surgeon who often dealt with patients suffering from a condition called hallux valgus deformity, also known as bunions. The traditional treatment method for this problem was surgery, which was associated with high costs, long recovery times, and a high risk of complications. Treace recognized the need for a more effective and less invasive treatment method and decided to develop a solution. The result of these efforts was the Lapiplasty system, which was FDA approved in 2019. It is a novel procedure for correcting bunions, allowing for three-dimensional alignment of the affected joint. The procedure is quick, safe, and allows patients to walk normally just a few weeks after the surgery. Since the development of the Lapiplasty system, Treace Medical Concepts has expanded its business model and now offers a wide range of orthopedic solutions for various indications. The company has three main divisions: feet and ankles, hands and wrists, and shoulders and elbows. Each division offers a variety of products and solutions to treat a wide range of disorders and conditions. The most well-known products include the Lapiplasty system, as well as the KinetiSense system for motion analysis and the G-Force system for treating tennis elbow. Treace Medical Concepts aims not only to develop innovative products but also to ensure that these products are easily accessible to doctors and patients. The company has formed partnerships with leading medical institutions and distribution partners around the world to ensure that the products can be quickly and effectively used in clinical practice. The company is also dedicated to research and development, investing a significant portion of its revenue in developing new products and technologies. The company has already filed several patents and works closely with doctors and scientists to develop new solutions for a wide range of orthopedic problems. Overall, Treace Medical Concepts has the potential to change the way we treat orthopedic problems. The company has managed to be innovative while keeping the needs and requirements of doctors and patients in mind. With a strong corporate culture and dedicated leadership, Treace Medical Concepts has all the prerequisites to continue to succeed and improve the treatment of orthopedic problems worldwide. Treace Medical Concepts is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Treace Medical Concepts stock

Current Liabilities of Treace Medical Concepts is 30.63 M USD in 2025.

Current Liabilities of Treace Medical Concepts changed from 59.23 M USD to 30.63 M USD, representing a -48.28% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities Treace Medical Concepts since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Treace Medical Concepts historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Treace Medical Concepts

All Key Metrics — Treace Medical Concepts